Acute hepatitis associated with Colpachi intake. Apropos of 5 cases;Hepatitis aguda asociada al consumo de Copalchi. A propósito de 5 casos

Gastroenterologia y Hepatologia

Volumn 30, Issue 2, 2007, Pages 66-68

  Bruguera, Miguel ^a,d   Herrera, Samuel ^a   Lázaro, Edurne ^b   Madurga, Mariano ^b   Navarro, Marta ^c   De Abajo, Francisco J ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Division de Farmacoepidemiologia y Farmacovigilancia   (Spain)

^c Centro de Atención Primaria Antón Borja   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; COLPACHI; ENALAPRIL; GLIBENCLAMIDE; HERBACEOUS AGENT; LORAZEPAM; TRAMADOL; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FEMALE; HUMAN; LABORATORY TEST; LIVER TOXICITY; MALE; MEDICAL LITERATURE;

EID: 33947223743     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13099265     Document Type: Article

References (17)

1. Koretz RL, Rotblatt M. Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly. Clin Gastroenterol Hepatol. 2004;2:957-67.
2. Levy C, Seeff LD, Lindor KD. Use of herbal supplements for chronic liver diseases. Clin Gastroenterol Hepatol. 2004;2:947-56.
3. Tirona RG, Bailey DG. Herbal product-drug interactions mediated by induction. Br J Clin Pharmacol. 2006;61:677-81.
4. Andrade RJ, Lucena MI, Garcia-Cortés M. Hepatotoxicidad por infusión de hierbas. Gastroenterol Hepatol. 2002;25:327-32.
5. Stedman C: Herbal hepatotoxicity. Semin Liver Dis. 2002;22: 195-206.
6. Pittler MH, Ernst E. Systematic review: hepatotoxic events associated with herbal products. Aliment Pharmacol Ther. 2003; 18:451-71.
7. Schiano TD. Hepatotoxicity of complementary and alternative medicines. Clin Liver Dis. 2003;7:453-73.
8. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol. 2005;43:901-10.
9. Wurtz AS, Vial T, Isoard B, Saillard E. Possible hepatoxicity from Copaltra, an herbal medicine. Ann Pharmacother. 2002; 36:941-2.
10. Vial T, Wurtz AS, Liautard C, Djezzar S. Hepatitis induced by herbal medicines: a report of 5 cases [abstract]. Presented at 6 th Annual Meeting of the European Society of Pharmacovigilance. Budapest, 28-29 de septiembre de 1998.
11. Clarke AT, Mills PR. Atorvastatin associated with liver disease. Dig Dis Liver. En prensa 2006.
12. Ingelmo M, Vivancos J, Bruguera M, Sierra J, Balcells A. Vascultitis por hipersensibilidad y hepatitis granulomatosa inducida por glibenclamida: description de un caso. Med Clin (Barc). 1980;75:306-8.
13. González de la Puente MA, Calderón E, Espinosa R, Rincón M, Varela JM. Fatal hepatotoxiciy associated with enalapril. Ann Pharmacother. 2001;35:1492.
14. Paris RR, Bastien M. Action hypoglycemiante des Copalchis. Ann Pharmac Franç. 1960;18:205-19.
15. Peris JB, Stübing G, Vanaclocha B. Fitoterapia aplicada. Valencia: MI Colegio Oficial de Farmacêuticos; 1995. p. 236.
16. Agenda Española de Medicamentos y Productos Sanitarios. Suspension de comercialización de la especialidad farmacéutica Exolise®: extracto etanólico de Camellia sinensis (té verde). Nota informativa 2003/03, 7 de abril de 2003. Disponible en: http://www.agemed.es/ actividad/alertas/usoHumano/seguridad/exolise.htm
17. Pedros C, Cereza G, García N, Laporte JR. Hepatotoxicidad por extracto etanólico seco de Camellia sinensis. Med Clin (Barc). 2003;12:598-9.